Santen Pharmaceutical Co., Ltd.
4536
Peringkat dalam Saham
#4331
Santen Pharmaceutical Co., Ltd. is a global enterprise engaged in the research,... Santen Pharmaceutical Co., Ltd. is a global enterprise engaged in the research, development, manufacturing, and marketing of both pharmaceutical products and medical devices. The company's primary focus lies in ophthalmic solutions, addressing a variety of eye conditions. Its pipeline for glaucoma and ocular hypertension includes several key assets: DE-111, currently in Phase III clinical trials; DE-117, available for sale in Japan; DE-126, progressing through Phase IIb trials; DE-128, which is on the market in Europe and undergoing Phase II/III trials in the United States; and DE-130A, also in Phase III development. Beyond glaucoma, Santen's offerings extend to other ocular ailments. It provides DE-114A for allergic conjunctivitis and DE-076C for vernal keratoconjunctivitis. Furthermore, DE-109 is in Phase III clinical trials for the treatment of uveitis. The company is also active in addressing myopia with DE-127, currently in Phase II/III trials in Japan and Phase III in other Asian markets, alongside STN1013400, which is in Phase I trials. For dry eye, Santen offers DE-089C, which has successfully concluded its Phase III clinical trials. In addition to its prescription portfolio, the company produces and sells various over-the-counter (OTC) pharmaceutical products. Founded in 1890 under the name Santendo Pharmaceutical Co., Ltd., the company rebranded to its current name, Santen Pharmaceutical Co., Ltd., in 1958. It is headquartered in Osaka, Japan.
Harga Saham
$11.35
Terakhir disinkronkan: 2026-10-16
Kapitalisasi Pasar
$3.65B
Perubahan (1 hari)
1.55%
Perubahan (1 tahun)
-0.91%
Negara
JP
Perdagangan Santen Pharmaceutical Co., Ltd. (4536)
Kategori
Healthcare
Kapitalisasi pasar dari Santen Pharmaceutical Co., Ltd.(4536)
Kapitalisasi Pasar: $3.65B
Per October 2026, Santen Pharmaceutical Co., Ltd. memiliki kapitalisasi pasar sebesar $3.65B. Ini menjadikan Santen Pharmaceutical Co., Ltd. sebagai perusahaan 4331st paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Santen Pharmaceutical Co., Ltd. dari 2010 hingga 2026
4536 dibandingkan dengan 5 teratas stocks paling populer
